市場調查報告書
商品編碼
1401910
到 2030 年非侵入式監測設備市場預測:按類型、適應症、最終用戶和地區分類的全球分析Non Invasive Monitoring Device Market Forecasts to 2030 - Global Analysis By Type, By Indication, By End User and By Geography |
根據Stratistics MRC預測,2023年全球非侵入式監測設備市場規模將達44億美元,預計2030年將達到91億美元,預測期內複合年成長率為10.8%。
非侵入性監測設備是無需在身體上打孔即可收集生理資料的醫療設備。這些設備,例如血壓計和脈搏血氧計,通常用於追蹤生命徵象。
據歐洲心臟網路稱,心血管疾病 (CVD) 導致歐洲約 390 萬人死亡,歐盟 (EU) 超過 180 萬人死亡。此外,2016年中國農村和都市區CVD死亡人數分別佔45.50%和43.16%。
慢性病盛行率上升
這些疾病的盛行率持續上升,增加了對高效、便捷的監測解決方案的需求。非侵入性設備提供了連續追蹤生命徵象的重要手段,無需侵入性操作,這與現代醫學對早期檢測和預防性護理的強調相一致。這一趨勢將推動市場向前發展,並推動非侵入性監測設備的創新和技術進步,以滿足不斷變化的醫療保健形勢和慢性疾病患者不斷成長的需求。
初期成本高
開發、製造和部署先進技術通常需要大量投資。這種經濟障礙可能會限制非侵入性監測設備的普及,特別是在預算有限的衛生系統中。成本因素已成為醫療保健組織的關鍵考慮因素,限制了他們投資先進監控解決方案的能力。解決此限制的措施包括策略定價模型、降低製造成本的合作以及努力使非侵入性監測設備對醫療保健提供者和患者來說在經濟上可行。可以考慮倡導有利的報銷政策。
政府努力促進醫療保健可近性
優先考慮改善衛生基礎設施和可近性的政策和計劃,特別是在發展中地區,將營造有利於採用非侵入性監測設備的環境。隨著各國政府尋求改善公共衛生成果並減輕衛生系統的壓力,支持遠端病患監測和居家照護技術的趨勢日益明顯。這種與政府醫療保健政策的一致性不僅擴大了市場範圍,而且還促進將非侵入性監測解決方案整合到更廣泛的醫療保健框架中,從而改善整體患者照護和結果。
資料安全問題
由於這些設備收集和傳輸敏感的醫療資料,因此詐欺的存取和資料外洩的風險是醫療保健提供者和患者的主要擔憂。患者資訊的洩漏會破壞對該技術的信任並阻礙普及。減輕這種威脅需要嚴格的加密協議、強大的網路安全措施並遵守隱私法規。在這個市場運作的公司必須優先考慮開發安全且合規的解決方案,醫療保健相關人員必須採取措施在不斷發展的非侵入性監測領域保護病患資料。我們在實施過程中需要保持警惕。
COVID-19 的爆發對市場產生了積極影響。大流行期間對病患監測的日益關注以及對遠端醫療解決方案的需求加速了非侵入性監測設備的採用。隨著居家醫療和遠端醫療醫療的重視以及醫院就診次數的減少,這些設備對於遠端監測患者生命徵象已變得至關重要。這次疫情凸顯了早期檢測和持續監測的重要性,推動了對非侵入性解決方案的需求,這些解決方案提供了一種有效且便捷的方法來追蹤傳統醫療環境之外的健康參數。
預計血壓計將成為預測期內最大的市場
血壓計佔據了很大的佔有率。隨著全球高血壓和心血管疾病盛行率不斷上升,對準確、便利的血壓監測解決方案的需求迅速增加。技術的進步促進了方便用戶使用型攜帶式設備的發展,增加了它們在臨床環境和家庭使用中的採用。數位功能、無線連接以及與行動健康應用程式的兼容性的整合使血壓計對於非侵入性監測更具吸引力。
醫院部門預計在預測期內複合年成長率最高
在預測期內,醫院的複合年成長率最高。從生命徵象監測儀到穿戴式健康追蹤器,非侵入性監測設備為醫院提供了一種有效的手段來持續追蹤患者的健康狀況,而無需進行侵入性手術。強調遠端患者監護以及將非侵入性設備整合到醫院工作流程中有助於改善患者照護、及時干預並簡化醫療服務。隨著醫院優先考慮現代化和以患者為中心的護理,對非侵入性監測設備的需求持續成長並塑造醫療保健業務的未來。
北美佔據重要地位,預計在預測期內將保持最大佔有率。該地區先進的醫療基礎設施和強大的研發能力推動了非侵入性監測技術的創新。預防保健醫療意識的提高和慢性病的高盛行率增加了對這些設備的需求。此外,政府的支持政策、人口高齡化的加劇以及先進醫療技術的採用也進一步推動了市場的發展。由於主要市場參與企業的存在和策略合作,北美在塑造非侵入式監控設備市場軌跡方面發揮主導作用。
由於醫療基礎設施的擴張和對技術進步的日益重視,亞太地區的複合年成長率最高。該地區人口眾多且多樣化,加上醫療保健意識不斷增強,正在推動對非侵入性監測解決方案的需求。亞太國家政府正在增加對醫療保健的投資,推動市場成長。慢性病的日益普及和向居家醫療的轉變進一步推動了非侵入性設備的採用。因此,亞太地區正在成為非侵入性監測技術發展的關鍵貢獻者和創新者。
According to Stratistics MRC, the Global Non Invasive Monitoring Device Market is accounted for $4.4 billion in 2023 and is expected to reach $9.1 billion by 2030 growing at a CAGR of 10.8% during the forecast period. A non-invasive monitoring device is a medical instrument that gathers physiological data without penetrating the body. These devices, such as blood pressure monitors or pulse oximeters, are commonly used to track vital signs.
According to the European Heart Network, Cardiovascular Diseases (CVDs) have been a cause of ~3.9 million deaths in Europe and more than 1.8 million deaths in the European Union (EU). Further, in China, CVDs led to 45.50% and 43.16% of total death in rural areas and urban areas, respectively, in 2016.
The rising prevalence of chronic diseases
The incidence of these conditions continues to rise, there is a growing demand for efficient and convenient monitoring solutions. Non-invasive devices provide a crucial means to continuously track vital signs without the need for invasive procedures, aligning with the contemporary healthcare emphasis on early detection and preventative care. This trend propels the market forward, fostering innovation and technological advancements in non-invasive monitoring devices to address the evolving healthcare landscape and the increasing needs of patients with chronic illnesses.
High initial costs
The development, manufacturing and implementation of sophisticated technologies often require substantial investments. This financial barrier can limit the widespread adoption of non-invasive monitoring devices, particularly in healthcare systems with constrained budgets. The cost factor becomes a crucial consideration for healthcare institutions, hindering their ability to invest in advanced monitoring solutions. Efforts to address this restraint may involve strategic pricing models, collaborations to reduce production costs, and advocacy for favorable reimbursement policies to make non-invasive monitoring devices more economically viable for both providers and patients.
Government initiatives to promote healthcare access
Policies and programs that prioritize enhanced healthcare infrastructure and accessibility, particularly in developing regions, foster a conducive environment for the adoption of non-invasive monitoring devices. As governments strive to improve public health outcomes and reduce the burden on healthcare systems, there is a growing inclination towards supporting technologies that enable remote patient monitoring and home-based care. This alignment with governmental healthcare agendas not only expands the market reach but also encourages the integration of non-invasive monitoring solutions into broader healthcare frameworks, enhancing overall patient care and outcomes.
Data security concerns
These devices collect and transmit sensitive health data, the risk of unauthorized access and data breaches is a major apprehension for both healthcare providers and patients. Instances of compromised patient information can erode trust in the technology and impede widespread adoption. Mitigating this threat requires stringent encryption protocols, robust cybersecurity measures, and adherence to privacy regulations. Companies operating in this market must prioritize the development of secure and compliant solutions, and healthcare stakeholders should stay vigilant in implementing measures to safeguard patient data in the evolving landscape of non-invasive monitoring.
The COVID-19 pandemic has positively impacted the market. The heightened focus on patient monitoring and the need for remote healthcare solutions during the pandemic accelerated the adoption of non-invasive monitoring devices. With an increased emphasis on home-based care and telemedicine to reduce hospital visits, these devices have become integral in monitoring patients' vital signs remotely. The pandemic underscored the importance of early detection and continuous monitoring, driving the demand for non-invasive solutions that provide effective and convenient ways to track health parameters outside traditional healthcare settings.
The blood pressure monitor is expected to be the largest during the forecast period
The blood pressure monitor has a significant share in the market. With a rising global prevalence of hypertension and cardiovascular diseases, the demand for accurate and convenient blood pressure monitoring solutions has surged. Technological advancements have led to the development of user-friendly and portable devices, contributing to increased adoption both in clinical settings and for home use. The integration of digital features, wireless connectivity, and compatibility with mobile health applications further enhances the appeal of blood pressure monitors in the non-invasive monitoring landscape.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals have the highest CAGR within the market over the forecast period. Non-invasive monitoring devices, ranging from vital sign monitors to wearable health trackers, offer hospitals efficient means to continuously track patients' health without invasive procedures. The emphasis on remote patient monitoring and the integration of non-invasive devices into hospital workflows contribute to improved patient care, timely interventions, and streamlined healthcare delivery. As hospitals prioritize modernization and patient-centric care, the demand for non-invasive monitoring devices continues to grow, shaping the future of healthcare practices.
North America holds a significant position and expected to hold a largest share over the forecast period. The region's advanced healthcare infrastructure, coupled with robust research and development activities, drives innovation in non-invasive monitoring technologies. Increasing awareness of preventive healthcare and a high prevalence of chronic diseases contribute to the demand for these devices. Additionally, supportive government policies, a growing aging population, and the adoption of advanced healthcare technologies further propel the market. The presence of key market players and strategic collaborations in North America solidify its leadership role in shaping the trajectory of the Non-Invasive Monitoring Device Market.
The Asia-Pacific region witnessed the highest CAGR in the market, driven by expanding healthcare infrastructure and a growing emphasis on technological advancements. The region's large and diverse population, coupled with rising healthcare awareness, fuels the demand for non-invasive monitoring solutions. Governments in several Asia Pacific countries are increasingly investing in healthcare, fostering market growth. The increasing prevalence of chronic diseases and a shift toward home healthcare further boost the adoption of non-invasive devices. As a result, Asia Pacific is emerging as a key contributor and innovator in the evolving landscape of non-invasive monitoring technologies.
Some of the key players in Non Invasive Monitoring Device Market include A&D Medical, Imacor, Abbott, Baxter, Koninklijke Philips N.V., CAS Medical Systems, Conmed Corporation, Deltex Medical Limited, General Electric, Medtronic, Vaso Corporation and Omron.
In October 2023, Baxter International Inc. (NYSE:BAX) announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.
In October 2023, Royal Philips a global leader in health technology announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound.